l General Information |
Product Name | Carmofur |
General description | Carmofur is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. |
Synonym | HCFU; 5-fluoro-N-hexyl-2,4-dioxopyrimidine-1-carboxamide |
Purity | ≥97.0%(HPLC) | CAS Number | 61422-45-5 |
Formula | C11H16FN3O3 | Molecular Weight | 257.265 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or off-white solid |
Solubility(25°C) | DMSO | ≥35mg/ml |
Ethanol | ~5mg/ml |
Water | Very slightly soluble |
l Biological Information |
Biochem/Physiol
Actions | Carmofur is an antimetabolite (pyrimidine analogue) antineoplastic derivative of 5-fluorouracil. (NCI) |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
